Skip to content

Group discussion effect on blood pressure

Comparison of the efficacy group discussion based on a healthy lifestyle in two methods family-centered and patient-centered on the control of hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015122317059N4
Enrollment
100
Registered
2016-07-11
Start date
2016-12-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension, Secondary hypertension

Interventions

Intervention 1: Intervention group 1: In patient-centered group discussion, group discussion sessions for an hour a week for four weeks in hospital clinics will be held. It is noteworthy that in this
Lifestyle
Intervention group 1: In patient-centered group discussion, group discussion sessions for an hour a week for four weeks in hospital clinics will be held. It is noteworthy that in this group of 50 subj
Intervention group 2: In family-centered group discussion, 50 patients and 50 members of the immediate family (spouse, child, sister, brother, parents) will participate. Group discussion sessions for

Sponsors

Vice chancellor for research, Urmia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Major inclusion and exclusion criteria: Ability to participate in the study; aged between thirty and sixty years; lack of underling disease; residence in the city of Orumieh; the use of drugs to control blood pressure will be entry requirements. The exclusion criteria will be: not wanting to continue cooperation; change location to another town; cure hypertension.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Five times. Method of measurement: Mercury sphygmomanometer.

Secondary

MeasureTime frame
Sweating , nausea , impotency , headaches. Timepoint: Two times. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026